Delivery Order SPE2DB20D3103-SPE2DB25FN7A2

Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,528.97, is for the delivery of RECTIV 0.4% ointment in 30-gram quantities. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,653.00 firm fixed-price contract is for the supply of 4568232833 RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a specific pharmaceutical product, "RECTIV 0.4% OINTMENT 30GM," with a ceiling value of $4,708.81 and a period of performance through September 9, 2024. The contract is a firm-fixed-price, delivery order type with no set-aside designation. AmerisourceBergen has been awarded numerous federal contracts by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RECTIV 0.4% ointment in 30-gram tubes. The contract has a ceiling value of $5,703.19 and an ultimate completion date of August 21, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor in the United States, will provide the requested pharmaceutical product to support federal healthcare...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of RECTIV 0.4% ointment, 30 grams, with a potential value of $3,886.90 and a completion date of February 27, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product. The contract has a ceiling value of $1,045.29 and is a firm fixed-price delivery order type. The award does not have any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RECTIV 0.4% OINTMENT 30GM pharmaceutical products. The $17,255.42 contract is a firm fixed-price agreement without any set-aside designation. The order will be fulfilled by AmerisourceBergen's Corporate Office division and is scheduled for completion by August 28, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
This is a federal delivery order contract (SPE2DX15D1053|SPE2DX25F6FJM) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,826.28 firm fixed-price contract is for the supply of RECTIV 0.4% ointment, 30 grams, with a completion date of December 27, 2024. This order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568082307 RECTIV 0.4% OINTMENT 30GM. The $1,345.90 contract has a performance period through May 1, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of RECTIV 0.4% OINTMENT 30GM, a pharmaceutical product, with a ceiling value of $1,182.51 and an ultimate completion date of August 21, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN7A2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RECTIV 0.4% ointment, a pharmaceutical product, with a ceiling value of $2,023.15. The contract is a firm-fixed price type with a period of performance through May 7, 2025. The place of performance is Conshohocken, Pennsylvania. This contract is not associated with a set-aside designation, indicating it was competed on an unrestricted basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the agency's medical supply needs.

Generated 8/10/25, 1:17 AM